AU2003290797A8 - Compositions and methods utilizing human gamma-hydroxybutyrate receptor - Google Patents

Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Info

Publication number
AU2003290797A8
AU2003290797A8 AU2003290797A AU2003290797A AU2003290797A8 AU 2003290797 A8 AU2003290797 A8 AU 2003290797A8 AU 2003290797 A AU2003290797 A AU 2003290797A AU 2003290797 A AU2003290797 A AU 2003290797A AU 2003290797 A8 AU2003290797 A8 AU 2003290797A8
Authority
AU
Australia
Prior art keywords
compositions
methods utilizing
human gamma
utilizing human
hydroxybutyrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003290797A
Other versions
AU2003290797A1 (en
Inventor
Christian Andriamampandry
Omar Taleb
Michel Maitre
Jean Paul Humbert
Eve Van Cauter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SLOWAVE Inc
Original Assignee
SLOWAVE Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SLOWAVE Inc filed Critical SLOWAVE Inc
Publication of AU2003290797A8 publication Critical patent/AU2003290797A8/en
Publication of AU2003290797A1 publication Critical patent/AU2003290797A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003290797A 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor Abandoned AU2003290797A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42619002P 2002-11-14 2002-11-14
US60/426,190 2002-11-14
PCT/US2003/036200 WO2004046315A2 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Publications (2)

Publication Number Publication Date
AU2003290797A8 true AU2003290797A8 (en) 2004-06-15
AU2003290797A1 AU2003290797A1 (en) 2004-06-15

Family

ID=32326319

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003290797A Abandoned AU2003290797A1 (en) 2002-11-14 2003-11-14 Compositions and methods utilizing human gamma-hydroxybutyrate receptor

Country Status (2)

Country Link
AU (1) AU2003290797A1 (en)
WO (1) WO2004046315A2 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4080274A (en) * 1968-08-20 1978-03-21 American Can Company Photopolymerization of lactone-epoxide mixtures with aromatic diazonium salts as photocatalyst
WO2000020590A2 (en) * 1998-10-06 2000-04-13 Incyte Pharmaceuticals, Inc. G-protein coupled receptor proteins

Also Published As

Publication number Publication date
WO2004046315A8 (en) 2004-08-26
WO2004046315A3 (en) 2004-11-18
AU2003290797A1 (en) 2004-06-15
WO2004046315A2 (en) 2004-06-03

Similar Documents

Publication Publication Date Title
PT1583542E (en) Compositions and methods for combination antiviral therapy
HK1077310A1 (en) Hydrogenated copolymer and composition thereof
GB0411940D0 (en) Methods and compositions
EP1701725A4 (en) Methods and compositions
AU2003267644A8 (en) Dental compositions and methods
EP1478276A4 (en) Novel targeted compositions for diagnostic and therapeutic use
AU2003287443A8 (en) Compositions and methods for pain reduction
AU2003299088A8 (en) Nocturnal muscle enhancing composition and method
EP1537089A4 (en) Compounds compositions and methods
AU2003299441A8 (en) Nf-hev compositions and methods of use
IL163876A0 (en) Therapeutic methods and compositions involving isovlav-3-ene and isoflavan structures
EP1536813A4 (en) Compositions and methods comprising protein activated receptor antagonists
GB0303609D0 (en) Novel therapeutic method and compositions
AU2003213120A8 (en) Human rnase iii and compositions and uses thereof
GB0212405D0 (en) Composition and its therapeutic use
GB0222945D0 (en) Therapeutic compositions
AU2003282722A8 (en) Therapeutic compositions
EP1583557A4 (en) Vaccine compositions and methods
GB0327050D0 (en) Therapeutic methods compositions and uses
AU2003268078A8 (en) Levothyroxine compositions and methods
AU2003290797A8 (en) Compositions and methods utilizing human gamma-hydroxybutyrate receptor
GB0207224D0 (en) Tenascin-W compositions and uses thereof
GB0303600D0 (en) Novel therapeutic method and compositions
GB0205826D0 (en) Therapeutic compositions and methods
AU2003245524A8 (en) Cryosurgery compositions and methods

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase